AKBA
Akebia Therapeutics Inc
Price:  
3.56 
USD
Volume:  
6,471,144.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

AKBA Relative Valuation

-196.3%
Upside

As of 2025-06-16, the Relative Valuation of Akebia Therapeutics Inc (AKBA) is (3.43) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.56 USD, the upside of Akebia Therapeutics Inc based on Relative Valuation is -196.3%.

The range of the Relative Valuation is (3.30) - (3.69) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 19.1x - 25.1x 23.1x
Forward P/E multiples 15.7x - 21.4x 16.6x
Fair Price (3.30) - (3.69) (3.43)
Upside -192.7% - -203.7% -196.3%
3.56 USD
Stock Price
(3.43) USD
Fair Price

AKBA Relative Valuation - Historical P/E Data

Date P/E
2025-06-13 -20.63
2025-06-12 -21.16
2025-06-11 -20.69
2025-06-10 -22.72
2025-06-09 -22.20
2025-06-06 -23.01
2025-06-05 -21.39
2025-06-04 -21.10
2025-06-03 -19.82
2025-06-02 -18.84
2025-05-30 -17.56
2025-05-29 -17.45
2025-05-28 -16.69
2025-05-27 -16.92
2025-05-23 -16.58
2025-05-22 -16.40
2025-05-21 -16.29
2025-05-20 -16.92
2025-05-19 -16.23
2025-05-16 -15.13
2025-05-15 -14.72
2025-05-14 -14.20
2025-05-13 -14.37
2025-05-12 -14.08
2025-05-09 -14.78
2025-05-08 -15.19
2025-05-07 -14.26
2025-05-06 -13.45
2025-05-05 -13.56
2025-05-02 -14.20
2025-05-01 -13.85
2025-04-30 -13.97
2025-04-29 -14.08
2025-04-28 -14.08
2025-04-25 -13.79
2025-04-24 -13.22
2025-04-23 -12.52
2025-04-22 -12.40
2025-04-21 -12.00
2025-04-17 -11.94
2025-04-16 -11.01
2025-04-15 -10.95
2025-04-14 -10.61
2025-04-11 -9.56
2025-04-10 -8.98
2025-04-09 -9.85
2025-04-08 -9.74
2025-04-07 -10.26
2025-04-04 -10.26
2025-04-03 -10.90